Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies
Background/ObjectivesProstate-specific membrane antigen (PSMA) is overexpressed in prostate hypercellularity, making it an effective target for molecular imaging and therapy of prostate cancer. PSMA is expressed in the neovasculature of hepatic malignancies and regulates tumor cell invasion and angi...
Saved in:
| Main Authors: | Fucen Liu, Liming Xiao, Ling Zhao, Yi Tao, Dan Huang, Zhengguo Chen, Chuandong He, Chunyan Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1547459/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brief Analysis of the Validation of Analytical Methods for Radiopharmaceuticals
by: Mengyi CHEN, et al.
Published: (2024-12-01) -
Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01) -
Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
by: D. V. Goryachev, et al.
Published: (2025-02-01) -
Strategies for Innovative Development of Tumor-targeted Theranostic Radiopharmaceuticals
by: HUANG Xuhu1, 2, 3, CHEN Huan1, 2, 3, LI Kexin1, 2, 3, WANG Ning1, 2, 3, ZHUANG Jin1, 2, 3, LI Hongyu1, 2, 3, DU Jin2, 3, 4
Published: (2025-04-01) -
Clinical and imaging features of primary thyroid MALT lymphoma
by: Liming Xiao, et al.
Published: (2025-05-01)